251 related articles for article (PubMed ID: 30779985)
1. Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier.
Dey M; Das M; Chowhan A; Giri TK
Int J Biol Macromol; 2019 Jun; 130():34-49. PubMed ID: 30779985
[TBL] [Abstract][Full Text] [Related]
2. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides.
Yuan H; Guo C; Liu L; Zhao L; Zhang Y; Yin T; He H; Gou J; Pan B; Tang X
Carbohydr Polym; 2023 Jul; 312():120838. PubMed ID: 37059563
[TBL] [Abstract][Full Text] [Related]
3. Scalable and cleavable polysaccharide nanocarriers for the delivery of chemotherapy drugs.
Wang H; Dai T; Li S; Zhou S; Yuan X; You J; Wang C; Mukwaya V; Zhou G; Liu G; Wei X; Dou H
Acta Biomater; 2018 May; 72():206-216. PubMed ID: 29567106
[TBL] [Abstract][Full Text] [Related]
4. Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review.
Lang X; Wang T; Sun M; Chen X; Liu Y
Int J Biol Macromol; 2020 Jul; 154():433-445. PubMed ID: 32194103
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide-based micro/nanocarriers for oral colon-targeted drug delivery.
Zhang L; Sang Y; Feng J; Li Z; Zhao A
J Drug Target; 2016 Aug; 24(7):579-89. PubMed ID: 26766303
[TBL] [Abstract][Full Text] [Related]
6. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
[TBL] [Abstract][Full Text] [Related]
7. Polysaccharides based nanomaterials for targeted anti-cancer drug delivery.
Dheer D; Arora D; Jaglan S; Rawal RK; Shankar R
J Drug Target; 2017 Jan; 25(1):1-16. PubMed ID: 27030377
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of Oral Bioavailability of Protein and Peptide by Polysaccharide-based Nanoparticles.
Islam MM; Raikwar S
Protein Pept Lett; 2024; 31(3):209-228. PubMed ID: 38509673
[TBL] [Abstract][Full Text] [Related]
9. Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway.
Wang D; Jiang Q; Dong Z; Meng T; Hu F; Wang J; Yuan H
Adv Drug Deliv Rev; 2023 Dec; 203():115130. PubMed ID: 37913890
[TBL] [Abstract][Full Text] [Related]
10. Oral delivery of anticancer drugs: challenges and opportunities.
Thanki K; Gangwal RP; Sangamwar AT; Jain S
J Control Release; 2013 Aug; 170(1):15-40. PubMed ID: 23648832
[TBL] [Abstract][Full Text] [Related]
11. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
[TBL] [Abstract][Full Text] [Related]
12. Oral administration of natural polyphenol-loaded natural polysaccharide-cloaked lipidic nanocarriers to improve efficacy against small-cell lung cancer.
Xie X; Li Y; Zhao D; Fang C; He D; Yang Q; Yang L; Chen R; Tan Q; Zhang J
Nanomedicine; 2020 Oct; 29():102261. PubMed ID: 32621880
[TBL] [Abstract][Full Text] [Related]
13. Newly Designed Silica-Containing Redox Nanoparticles for Oral Delivery of Novel TOP2 Catalytic Inhibitor for Treating Colon Cancer.
Vong LB; Kimura S; Nagasaki Y
Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28736844
[TBL] [Abstract][Full Text] [Related]
14. Drug nanodelivery systems based on natural polysaccharides against different diseases.
Rehman A; Jafari SM; Tong Q; Riaz T; Assadpour E; Aadil RM; Niazi S; Khan IM; Shehzad Q; Ali A; Khan S
Adv Colloid Interface Sci; 2020 Oct; 284():102251. PubMed ID: 32949812
[TBL] [Abstract][Full Text] [Related]
15. Materials and structure of polysaccharide-based delivery carriers for oral insulin: A review.
Wang X; Sun H; Mu T
Carbohydr Polym; 2024 Jan; 323():121364. PubMed ID: 37940264
[TBL] [Abstract][Full Text] [Related]
16. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
[TBL] [Abstract][Full Text] [Related]
17. The application of polysaccharide-based nanogels in peptides/proteins and anticancer drugs delivery.
Zhang L; Pan J; Dong S; Li Z
J Drug Target; 2017 Sep; 25(8):673-684. PubMed ID: 28462610
[TBL] [Abstract][Full Text] [Related]
18. Nanocarrier based approaches for targeting breast cancer stem cells.
Pindiprolu SKSS; Krishnamurthy PT; Chintamaneni PK; Karri VVSR
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):885-898. PubMed ID: 28826237
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
20. Advances in oral delivery of anti-cancer prodrugs.
Jain AK; Jain S
Expert Opin Drug Deliv; 2016 Dec; 13(12):1759-1775. PubMed ID: 27292717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
